From The Advisory Board

Case Study: Sexual Dysfunction Evaluation After Breast Cancer at an Oncology Sexual Health Clinic

Case Study: Sexual Dysfunction Evaluation After Breast Cancer at an Oncology Sexual Health Clinic

A case report that looks into a breast cancer survivor experiencing sex-related headaches after treatment.

Hot Topics From the 2015 Gastrointestinal Cancers Symposium

Hot Topics From the 2015 Gastrointestinal Cancers Symposium

Steven J. Cohen, MD, CTA Advisory Board member highlights key science from the 2015 Gastrointestinal Cancer Symposium.

Reflecting on Treatment Strategies for Acute Leukemia

Reflecting on Treatment Strategies for Acute Leukemia

Leukemia is sometimes a solid, metastatic, and invasive neoplasm, but this is forgotten when leukemia is viewed as only a "liquid" cancer.

Review of CHAARTED Trial Results

Review of CHAARTED Trial Results

CTA Advisory Board member, Neal Shore, MD, puts CHAARTED trial results into context.

MM-398: A Potential New Option for Metastatic Pancreatic Cancer?

MM-398: A Potential New Option for Metastatic Pancreatic Cancer?

CTA Board Member Steven Cohen, MD, discusses exciting advances regarding treatment options for metastatic pancreatic cancer.

Treatment Deintensification for HPV-Associated Oropharynx Cancer

Treatment Deintensification for HPV-Associated Oropharynx Cancer

The Eastern Cooperative Oncology Group (ECOG) conducted a trial to investigate whether treatment deintensification was feasible in patients with HPV-associated cancer.

Targeted Immunotherapy for Prostate Cancer with PROSTVAC: Interview with Neal Shore, MD, FACS

Targeted Immunotherapy for Prostate Cancer with PROSTVAC: Interview with Neal Shore, MD, FACS

Neal D. Shore, MD, FACS, sits down with CTA to discuss PROSTVAC as a targeted immunotherapy for prostate cancer.

What to Consider When It Comes to Surgery in Elderly Patients With Cancer

What to Consider When It Comes to Surgery in Elderly Patients With Cancer

Dr. Jeffrey Farma provides his insight on treating the elderly patient population in the surgical oncology setting.

Improving Survival in Advanced NSCLC: Multiple Lines of Chemotherapy Make a Difference

Improving Survival in Advanced NSCLC: Multiple Lines of Chemotherapy Make a Difference

Oncologists who care for non-small cell lung cancer (NSCLC) patients need to develop management strategies.

The Resurgence of Interest in Immune Therapy for Metastatic Renal Carcinoma

The Resurgence of Interest in Immune Therapy for Metastatic Renal Carcinoma

Immune therapies hold substantial promise to improve therapeutic options for patients with metastatic renal cancer.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs